MLchartDataset catalogue

m-azidopyrimethamine

Term · Oncology and biomedicine · MLC-T-ONC-015029

An antifolate derived from diaminopyrimidine with cytotoxic properties. With a mechanism of action similar to that of methotrexate (MTX), m-azidopyrimethamine blocks tetrahydrofolate synthesis, resulting in depletion of nucleotide precursors and inhibition of DNA, RNA and protein synthesis. This agent is more lipophilic but less potent than MTX.

Table 1. Record
IdentifierMLC-T-ONC-015029
FieldOncology and biomedicine
AbbreviationMZP
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015029",
  "term": "m-azidopyrimethamine",
  "field": "Oncology and biomedicine",
  "definition": "An antifolate derived from diaminopyrimidine with cytotoxic properties. With a mechanism of action similar to that of methotrexate (MTX), m-azidopyrimethamine blocks tetrahydrofolate synthesis, resulting in depletion of nucleotide precursors and inhibition of DNA, RNA and protein synthesis. This agent is more lipophilic but less potent than MTX.",
  "abbreviation": "MZP",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/m-azidopyrimethamine/"
}

Record 10,687 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.